Showing 2501–2550 of 12124 results .
| Symbol | Name | Price | Day % | Short % | Analyst | Short-Term | Long-Term | Div Score | Composite | Naive Forecast | Adjusted Forecast | Reliability | Surprise % | P/E | Beta | Div Yield (1yr) | Div Yield (3yr) | Div Yield (5yr) | Next Earnings | Sector | 52W % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | 14.07 | +2.85% | 46.8% | Buy | ★★☆☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -2.4 | -2.8% | -1.8% | 64% | +0.00% | — | 1.93 | — | — | — | Aug 6 | Healthcare | +96.5% | 2.0B |
| FONR | Fonar Corporation | 19.10 | +0.03% | 1.1% | — | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -3.8 | -0.0% | -0.0% | 69% | +0.00% | 19.1 | — | — | — | — | May 14 | Healthcare | +31.7% | 120.3M |
| ADXN | Addex Therapeutics Ltd | 6.65 | -2.49% | 0.5% | — | ★☆☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -9.6 | -5.6% | -4.4% | 78% | +0.00% | — | 1.98 | — | — | — | Sep 1 | Healthcare | -15.0% | 8.4M |
| ENTA | Enanta Pharmaceuticals, Inc. | 13.16 | -0.53% | 9.1% | Strong Buy | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | 1.2 | +0.5% | +0.4% | 80% | +0.00% | — | 1.01 | — | — | — | Aug 10 | Healthcare | +123.1% | 382.7M |
| GRAL | GRAIL, Inc. | 71.68 | -3.03% | 16.9% | Buy | ★★⯪☆☆ | ★★⯪☆☆ | ☆☆☆☆☆ | 7.5 | +15.1% | +6.7% | 44% | +0.00% | — | — | — | — | — | May 5 | Healthcare | +92.4% | 3.1B |
| DVA | DaVita Inc. | 194.36 | -1.39% | 17.3% | — | ★★★★☆ | ★★★⯪☆ | ☆☆☆☆☆ | 0.8 | +0.1% | +0.0% | 22% | +0.00% | 18.7 | 0.84 | — | — | — | Aug 5 | Healthcare | +44.6% | 12.5B |
| NGNE | Neurogene Inc. | 28.34 | +3.05% | 28.5% | Strong Buy | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | 6.4 | +10.1% | +5.3% | 53% | +0.00% | — | 2.08 | — | — | — | Aug 11 | Healthcare | +59.7% | 447.8M |
| BJDX | Bluejay Diagnostics, Inc. | 2.14 | -1.83% | 0.7% | — | ★☆☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -4.2 | +1.9% | +1.1% | 58% | +0.94% | — | — | — | — | — | — | Healthcare | -65.7% | 2.2M |
| HOTH | Hoth Therapeutics, Inc. | 1.36 | +0.00% | 4.3% | — | ★☆☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | 3.7 | +24.7% | +9.0% | 36% | +75.85% | — | 0.58 | — | — | — | Aug 7 | Healthcare | +104.8% | 26.0M |
| NXL | Nexalin Technology, Inc. | 0.61 | +4.45% | 3.0% | Buy | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -1.8 | -3.2% | -1.4% | 46% | +16.69% | — | — | — | — | — | — | Healthcare | -50.0% | 13.1M |
| PLSM | Pulsenmore Ltd. | 4.65 | +1.53% | 0.8% | — | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -8.1 | -13.3% | -4.3% | 32% | +0.00% | — | 0.29 | — | — | — | — | Healthcare | -36.8% | 30.2M |
| FDMT | 4D Molecular Therapeutics, Inc. | 9.91 | +10.48% | 26.7% | Buy | ★★☆☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -5.3 | -9.5% | -5.6% | 59% | +0.00% | — | 2.76 | — | — | — | May 7 | Healthcare | +147.8% | 518.1M |
| LFMD | LifeMD, Inc. | 4.28 | -6.75% | 14.5% | Strong Buy | ★★☆☆☆ | ★⯪☆☆☆ | ☆☆☆☆☆ | 4.8 | +7.2% | +3.5% | 48% | +0.00% | — | 2.02 | — | — | — | Aug 5 | Healthcare | -66.7% | 207.0M |
| GTBP | GT Biopharma, Inc. | 0.48 | +7.36% | 5.8% | Strong Buy | ★★⯪☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -1.4 | -6.9% | -2.2% | 31% | +0.00% | — | 0.64 | — | — | — | Aug 12 | Healthcare | -82.8% | 17.2M |
| AQST | Aquestive Therapeutics, Inc. | 4.02 | +0.00% | 12.6% | Strong Buy | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | 2.9 | +2.9% | +2.1% | 71% | +0.00% | — | 1.50 | — | — | — | Aug 11 | Healthcare | +48.3% | 504.3M |
| PALI | Palisade Bio, Inc. | 2.12 | +2.91% | 15.5% | Strong Buy | ★★☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -2.1 | -4.4% | -2.3% | 52% | +0.00% | 17.7 | — | — | — | — | Aug 11 | Healthcare | +178.9% | 368.4M |
| CRVO | CervoMed Inc. | 3.11 | -0.96% | 4.4% | Strong Buy | ★☆☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -9.6 | -22.0% | -10.0% | 45% | +0.00% | — | -4.47 | — | — | — | Aug 13 | Healthcare | -56.5% | 28.8M |
| XERS | Xeris Biopharma Holdings, Inc. | 6.16 | -2.53% | 7.4% | — | ★★★⯪☆ | ★★★☆☆ | ☆☆☆☆☆ | 8.5 | +11.0% | +8.7% | 79% | +0.00% | 88.0 | 0.92 | — | — | — | Aug 6 | Healthcare | +22.0% | 1.1B |
| HURA | TuHURA Biosciences, Inc. | 2.26 | -3.83% | 16.3% | Strong Buy | ★★☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | 37.9 | +47.8% | +38.1% | 80% | +0.00% | — | — | — | — | — | Aug 13 | Healthcare | -23.2% | 143.9M |
| PEPG | PepGen Inc. | 1.50 | +0.00% | 7.1% | Strong Buy | ★☆☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -0.2 | +0.0% | +0.0% | 32% | +0.00% | — | — | — | — | — | May 12 | Healthcare | +4.2% | 103.8M |
| LITS | Lite Strategy, Inc. | 1.01 | -0.98% | 0.3% | — | ★★☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -7.5 | -2.8% | -2.7% | 97% | +0.00% | — | 0.08 | — | — | — | May 13 | Healthcare | -54.5% | 34.4M |
| QNTM | Quantum Biopharma Ltd. | 6.86 | -2.28% | 3.8% | — | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -2.7 | +2.3% | +1.0% | 43% | +0.00% | — | 0.36 | — | — | — | Aug 12 | Healthcare | -54.9% | 43.9M |
| RNTX | Rein Therapeutics, Inc. | 1.11 | +0.00% | 0.5% | Strong Buy | ★★☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | 11.3 | +24.3% | +10.7% | 44% | +0.00% | — | 1.42 | — | — | — | Aug 12 | Healthcare | -42.5% | 94.9M |
| ZVRA | Zevra Therapeutics, Inc. | 11.59 | +1.67% | 7.6% | — | ★★★⯪☆ | ★★★★⯪ | ☆☆☆☆☆ | 0.7 | -1.6% | -1.3% | 80% | +0.00% | 5.8 | 0.88 | — | — | — | May 6 | Healthcare | +33.8% | 685.1M |
| CAPR | Capricor Therapeutics, Inc. | 29.96 | +2.92% | 20.8% | Strong Buy | ★★⯪☆☆ | ★★⯪☆☆ | ☆☆☆☆☆ | 0.3 | -2.6% | -1.6% | 61% | +0.00% | — | 0.48 | — | — | — | Aug 11 | Healthcare | +194.3% | 1.7B |
| ARQT | Arcutis Biotherapeutics, Inc. | 21.46 | +0.09% | 15.0% | — | ★★☆☆☆ | ★★★☆☆ | ☆☆☆☆☆ | -1.1 | -0.1% | -0.1% | 51% | +0.00% | — | 1.59 | — | — | — | Aug 5 | Healthcare | +64.4% | 2.7B |
| XENE | Xenon Pharmaceuticals Inc. | 54.73 | -0.11% | 4.0% | Strong Buy | ★★★★☆ | ★★★⯪☆ | ☆☆☆☆☆ | 3.3 | +0.1% | +0.1% | 71% | +0.00% | — | 0.65 | — | — | — | May 7 | Healthcare | +82.0% | 5.3B |
| BDMD | Baird Medical Investment Holdin | 1.49 | -5.70% | 1.6% | — | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -3.0 | +2.2% | +0.8% | 34% | +0.00% | — | -1.19 | — | — | — | May 15 | Healthcare | -59.0% | 47.7M |
| BBLG | Bone Biologics Corp | 1.32 | +1.15% | 0.6% | Strong Buy | ★☆☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -0.5 | -1.1% | -0.9% | 80% | +0.00% | — | 0.53 | — | — | — | Aug 7 | Healthcare | -75.3% | 2.4M |
| CLLS | Cellectis S.A. | 3.52 | -3.03% | 0.6% | Buy | ★☆☆☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | 2.0 | +3.1% | +2.5% | 80% | +0.00% | — | — | — | — | — | Aug 11 | Healthcare | +148.6% | 354.2M |
| ANNX | Annexon, Inc. | 5.42 | +0.93% | 15.8% | Strong Buy | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -0.1 | -0.9% | -0.7% | 73% | +0.00% | — | 1.22 | — | — | — | May 7 | Healthcare | +163.2% | 888.0M |
| TOVX | Theriva Biologics, Inc. | 0.28 | -8.16% | 8.8% | — | ★☆☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -7.3 | -5.1% | -2.1% | 41% | +0.00% | — | 1.18 | — | — | — | Aug 14 | Healthcare | -42.9% | 13.0M |
| LMAT | LeMaitre Vascular, Inc. | 94.65 | +0.12% | 6.3% | Buy | ★★★⯪☆ | ★★★★☆ | ★★⯪☆☆ | 2.6 | -0.1% | -0.0% | 41% | +0.00% | 34.8 | 0.60 | 0.93% | 0.92% | 0.97% | May 5 | Healthcare | +17.7% | 2.2B |
| PGNY | Progyny, Inc. | 25.56 | -0.51% | 9.7% | Strong Buy | ★★★⯪☆ | ★★☆☆☆ | ☆☆☆☆☆ | 1.6 | +0.4% | +0.1% | 26% | +0.00% | 33.2 | 0.91 | — | — | — | Aug 6 | Healthcare | +17.8% | 2.0B |
| FBIOP | Fortress Biotech, Inc. - 9.375% | 19.47 | +0.36% | — | — | ★☆☆☆☆ | ★☆☆☆☆ | ★☆☆☆☆ | -4.0 | -0.0% | -0.0% | 29% | +0.00% | — | 1.16 | — | 6.26% | 9.47% | Aug 11 | Healthcare | +145.6% | — |
| TFX | Teleflex Incorporated | 128.64 | -0.79% | 8.2% | Hold | ★★★★☆ | ★★⯪☆☆ | ★★⯪☆☆ | 1.0 | +0.8% | +0.3% | 43% | +0.00% | 1837.7 | 0.81 | 1.16% | 0.88% | 0.73% | Jul 30 | Healthcare | +7.5% | 5.7B |
| CRON | Cronos Group Inc. Common Share | 2.84 | +0.00% | 2.1% | — | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -3.6 | +0.2% | +0.1% | 43% | +0.00% | inf | 1.23 | — | — | — | Aug 6 | Healthcare | +43.4% | 1.1B |
| EVO | Evotec SE | 3.07 | +3.72% | 0.0% | — | ★★☆☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -6.7 | -3.6% | -2.7% | 75% | +0.00% | — | 1.30 | — | — | — | May 6 | Healthcare | -25.4% | 1.1B |
| AMN | AMN Healthcare Services Inc | 28.97 | +3.72% | 7.9% | — | ★★☆☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -5.2 | -3.6% | -1.2% | 33% | +0.00% | — | 0.30 | — | — | — | Aug 6 | Healthcare | +32.3% | 1.1B |
| ALT | Altimmune, Inc. | 3.05 | -0.65% | 19.4% | Buy | ★☆☆☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -0.1 | +0.0% | +0.0% | 48% | +0.00% | — | 0.17 | — | — | — | Aug 11 | Healthcare | -43.5% | 593.1M |
| AKTX | Akari Therapeutics Plc | 16.43 | -25.89% | 20.6% | Buy | ★★⯪☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | 11.7 | +33.8% | +12.4% | 37% | +165.58% | inf | 0.65 | — | — | — | Aug 18 | Healthcare | -59.2% | 18.8M |
| PTN | Palatin Technologies, Inc. Common Stock | 14.00 | -4.63% | 8.8% | — | ★★☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -4.8 | -0.1% | -0.0% | 34% | +0.00% | 127.3 | -0.09 | — | — | — | — | Healthcare | +154.9% | 24.9M |
| TDOC | Teladoc Health, Inc. | 7.61 | +1.33% | 14.8% | Buy | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | 26.0 | +65.4% | +27.1% | 41% | +0.00% | — | 2.08 | — | — | — | Jul 29 | Healthcare | +10.8% | 1.4B |
| ALLR | Allarity Therapeutics, Inc. | 1.64 | -1.80% | 1.8% | — | ★★☆☆☆ | ⯪☆☆☆☆ | ☆☆☆☆☆ | -7.6 | -6.2% | -2.8% | 46% | +0.00% | — | 0.38 | — | — | — | — | Healthcare | +92.6% | 26.1M |
| INO | Inovio Pharmaceuticals, Inc. | 1.31 | +0.77% | 22.2% | Buy | ★★⯪☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -10.1 | -23.4% | -9.7% | 42% | +0.00% | — | — | — | — | — | Aug 12 | Healthcare | -37.6% | 107.8M |
| ALVO | Alvotech | 3.36 | -2.04% | 2.2% | Buy | ★☆☆☆☆ | ★☆☆☆☆ | ☆☆☆☆☆ | -7.9 | -10.7% | -7.1% | 67% | +0.00% | 33.6 | 0.21 | — | — | — | May 6 | Healthcare | -70.0% | 1.0B |
| PFE | Pfizer, Inc. | 26.18 | +0.15% | 2.8% | Buy | ★★⯪☆☆ | ★★☆☆☆ | ★★☆☆☆ | 0.3 | -0.0% | -0.0% | 80% | +0.00% | 20.0 | 0.30 | 7.02% | 6.87% | 5.86% | Jul 29 | Healthcare | +11.6% | 149.2B |
| OGN | Organon & Co. | 13.34 | -0.07% | 8.7% | Hold | ★★★⯪☆ | ★★☆☆☆ | ★☆☆☆☆ | -0.9 | +0.1% | +0.0% | 40% | +0.00% | 14.3 | 1.55 | 0.90% | 4.51% | — | Apr 30 | Healthcare | +44.2% | 3.5B |
| URGN | UroGen Pharma Ltd. | 28.13 | -1.95% | 14.2% | Strong Buy | ★★★⯪☆ | ★★☆☆☆ | ☆☆☆☆☆ | 3.4 | +4.5% | +1.9% | 42% | +0.00% | — | 1.59 | — | — | — | Aug 6 | Healthcare | +481.2% | 1.4B |
| GDTC | CytoMed Therapeutics Limited | 1.17 | +2.63% | 2.0% | — | ★★⯪☆☆ | ★★⯪☆☆ | ☆☆☆☆☆ | -1.5 | -0.0% | -0.0% | 16% | +0.00% | — | -0.17 | — | — | — | Apr 28 | Healthcare | -50.9% | 13.8M |